Skip to main content

UPDATE

April 2, 2024

CURIA appoints Cricketer Yuvraj Singh as Brand Ambassador

Yuvraj Singh, the former star all-rounder for the Indian cricket team, said, “It is a matter of great delight for me to join hands with CURIA, the app that empowers cancer patients by offering them quick, and correct information for their treatment, and is also boosting cancer research initiatives."

Article Short description

As a cancer survivor, icon, and influencer, Yuvraj Singh’s association as the Brand Ambassador is expected to strengthen CURIA’s presence across India. 

more description

CURIA, one of the leading cancer research and information apps, has joined hands with former Indian cricket star Yuvraj Singh. 

As a cancer survivor, icon, and influencer, Yuvraj Singh’s association as the Brand Ambassador is expected to strengthen CURIA’s presence across India. 

Cancer is the biggest cause of fatalities in India as well as in almost all major countries of the world. The disease is not only life-threatening but also misinformation, and a lack of access to quality care in most parts of the country is a matter of enormous concern.

Without authentic information and guidance, precious time is wasted, and the patients are denied timely and effective care. They thus incur additional costs on below-par treatment, and it is common to see this lack of timely care leading to a preventable fatality. 

This is where CURIA has rapidly emerged as a game-changing one-stop platform for all cancer-related information and guidance in India. 

It is a mobile application developed by OncoCoin AG, a Swiss-based wholly owned subsidiary of Innoplexus AG. OncoCoin structures trillions of datapoints from published and unpublished data using its patented AI and blockchain technologies. The information is tailored by parameters such as demographics, cancer type, stage, and possible mutations, to generate the most relevant insights for quick decision-making.

Yuvraj Singh, the former star all-rounder for the Indian cricket team, said, “It is a matter of great delight for me to join hands with CURIA, the app that empowers cancer patients by offering them quick, and correct information for their treatment, and is also boosting cancer research initiatives."

Prediabetes & type 2 #diabetes are largely preventable. 

Pelvic floor muslces tend to weaken with age & may put you at risk of developing a condition known as pelvic organ prolapse (POP) where your pelvic organs begin to droop. Practice regular #Kegel #exercises to strengthen your pelvic floor

Vitamin E is a ubiquitous ingredient in most skin care products, from lotions to serums to sunscreens & night creams This naturally occurring antioxidant protects your skin against free radicals & improves your skin texture by softening it
 

Share Article

Latest Top 10 Performing Funds


Scheme Name NAV on Holdings Returns (%) Fund Manager Rating
Tata Nifty Pvt Bank ETF 112.1161 ₹ 953.7591472 Cr 24.1384707538614% Sailesh Jain 1
ICICI Pru Technology Fund(G) 53.41 ₹ 35414.76052571 Cr 23.1765904789635% Sankaran Naren , Vaibhav Dusad , Priyanka Khandelwal 2
Edelweiss ETF - Nifty Bank 2047.9931 ₹ 72.31 Cr 22.3638817077987% Bhavesh Jain , Hardik Verma 3
SBI-ETF Nifty Bank 202.4212 ₹ 242503.74 Cr 22.2708812094408% Raviprakash Sharma 3
Kotak Banking ETF 205.2306 ₹ 379580.55 Cr 22.2131952311096% Devender Singhal , Satish Dondapati 3
Motilal Oswal Nifty Bank Index Fund-Reg(G) 7.3638 ₹ 4036.5684866 Cr 22.0669674905138% Swapnil P Mayekar 2
Tata Digital India Fund-Reg(G) 13.9041 ₹ 34333.78900578 Cr 19.4938524951637% Meeta Shetty , Rahul Singh 2
Aditya Birla SL Digital India Fund(G) 51.49 ₹ 38115.86 Cr 19.046875% Kunal Sangoi 5
Kotak Small Cap Fund(G) 61.52 ₹ 124241.39 Cr 18.6944214108026% Pankaj Tibrewal 2
Quant Small Cap Fund(G) 38.9382 ₹ 176.1202212 Cr 17.7394878340161% Ankit Pande , Vasav Sahgal , Sanjeev Sharma 1

Scheme Name NAV on Holdings Returns (%) Fund Manager Rating

Scheme Name NAV on Holdings Returns (%) Fund Manager Rating